Polyautoimmunity in Patients with LPS-Responsive Beige-Like Anchor (LRBA) Deficiency

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Polyautoimmunity involves multiple autoimmune disorders in one patient.
• Lipopolysaccharide (LPS)-responsive beige-like anchor (LRBA) deficiency is a monogenic cause of polyautoimmunity.
• Understanding LRBA deficiency's role in polyautoimmunity is critical.

Purpose of the Study:

• To characterize polyautoimmunity in patients with LRBA deficiency.
• To highlight the prevalence and spectrum of autoimmune diseases in LRBA deficiency.
• To inform early diagnosis and treatment strategies.

Main Methods:

• Retrospective analysis of 14 LRBA deficiency patients with confirmed autoimmunity.
• Collection of demographic, clinical, laboratory, and molecular data.
• Literature review comparing findings with reported LRBA deficiency cases.

Main Results:

• Polyautoimmunity was observed in 64.2% of studied LRBA deficiency patients.
• Autoimmune cytopenias were the most common complication (7/9 patients).
• Literature review indicated 74.5% of LRBA deficient patients have polyautoimmunity, with diverse autoimmune conditions.

Conclusions:

• LRBA gene mutations are a significant cause of monogenic polyautoimmunity.
• Increased awareness of this association aids early diagnosis.
• Prompt treatment is essential for patients with LRBA deficiency-associated polyautoimmunity.